Skip to main content
. Author manuscript; available in PMC: 2015 Feb 17.
Published in final edited form as: Ann Surg Oncol. 2008 Sep 25;15(12):3369–3377. doi: 10.1245/s10434-008-0153-2

Table 3. Summary of studies investigating the effect of occult axillary lymph node metastases detected by serial sectioning and immunohistochemical staining for cytokeratin on disease-free and overall survival.

Study No. of patients with negative lymph nodes Patients with occult disease (%) Multivariate analysis of disease-free survival (RR and 95% CI) Multivariate analysis of overall survival (RR and 95% CI)
Tan et al. (2008)20 368 23 Node negative 1.0 Met. ≤0.2 mm 1.7 (1.0 to 2.9) Met. 0.3–2.0 mm 4.2 (2.1 to 8.5)a Node negative 1.0 Met. ≤0.2 mm 1.4 (0.9 to 2.2) Met. 0.3–2.0 mm 2.5 (1.3 to 4.6)b
Cummings et al. (2002)18 208 25 Node Negative 1.0 Occult metastasis 2.17 (1.16 to 4.05)c NS
Nasser et al. (1993)19 159 31 NS NS

RR, relative risk; 95% CI, 95% confidence interval; NS, not significant.

a

P < 0.001.

b

P = 0.02.

c

P = 0.015.